TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry

Vera Winter ,Rishi Chandiramani,Moritz Blum,Melissa Aquino,Ridhima Goel,Jaya Chandrasekhar,Rachel Singleton,Doreen Zeebregts,Usman Baber,Anastasios Roumeliotis,George Dangas,Roxana Mehran,Antonio Colombo,Samantha Sartori,Davide Cao,Pier Woudstra,Parke Wilde ,Marcel A.m Beijk ,Jan Tijssen ,Deborah N Kalkman ,Robbert De Winter ,Karel T Koch

doi:10.1016/j.jacc.2019.08.351

TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry

Vera Winter , Rishi Chandiramani + Show 20 more

Open Access

https://doi.org/10.1016/j.jacc.2019.08.351

Copy DOI

Journal: Journal of the American College of Cardiology	Publication Date: Sep 23, 2019
License type: elsevier-specific: oa user license

Affiliation: Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, Mount Sinai Hospital, Cardiovascular Institute of the South, Maria Cecilia Hospital, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam

#Rates Of Recurrent Ischemic Events #COMBO Stent + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Acute coronary syndrome (ACS) is associated with higher rates of recurrent ischemic events, myocardial infarction (MI), and stent thrombosis (ST). The dual-therapy COMBO stent combines a sirolimus-eluting biodegradable polymer with anti-CD34+ antibodies promoting rapid endothelialization of the

Full Text